186 related articles for article (PubMed ID: 9814691)
1. Antiphospholipid antibodies and atherosclerosis.
Matsuura E; Kobayashi K; Yasuda T; Koike T
Lupus; 1998; 7 Suppl 2():S135-9. PubMed ID: 9814691
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies in arterial thrombosis.
Koike T
Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
[TBL] [Abstract][Full Text] [Related]
3. Epitopes on beta2-GPI recognized by anticardiolipin antibodies.
Koike T; Ichikawa K; Kasahara H; Atsumi T; Tsutsumi A; Matsuura E
Lupus; 1998; 7 Suppl 2():S14-7. PubMed ID: 9814665
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome.
Matsuura E; Kobayashi K; Koike T; Shoenfeld Y; Khamashta MA; Hughes GR
Lupus; 2003; 12(7):550-4. PubMed ID: 12892397
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody-mediated atherosclerosis.
Matsuura E; Kobayashi K; Koike T; Shoenfeld Y
Autoimmun Rev; 2002 Dec; 1(6):348-53. PubMed ID: 12848990
[TBL] [Abstract][Full Text] [Related]
7. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
[TBL] [Abstract][Full Text] [Related]
8. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
Matsuura E
Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
[TBL] [Abstract][Full Text] [Related]
9. Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system.
Atsumi T; Khamashta MA; Amengual O; Donohoe S; Mackie I; Ichikawa K; Koike T; Hughes GR
Clin Exp Immunol; 1998 May; 112(2):325-33. PubMed ID: 9649198
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.
Wu R; Svenungsson E; Gunnarsson I; Haegerstrand-Gillis C; Andersson B; Lundberg I; Elinder LS; Frostegård J
Clin Exp Immunol; 1999 Mar; 115(3):561-6. PubMed ID: 10193434
[TBL] [Abstract][Full Text] [Related]
11. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen.
Kobayashi K; Kishi M; Atsumi T; Bertolaccini ML; Makino H; Sakairi N; Yamamoto I; Yasuda T; Khamashta MA; Hughes GR; Koike T; Voelker DR; Matsuura E
J Lipid Res; 2003 Apr; 44(4):716-26. PubMed ID: 12562869
[TBL] [Abstract][Full Text] [Related]
12. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
13. Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I.
Matsuura E; Kobayashia K; Koikeb T; Shoenfeld Y; Khamashta MA; Hughes GR
Immunobiology; 2003; 207(1):17-22. PubMed ID: 12638898
[TBL] [Abstract][Full Text] [Related]
14. Atherosclerosis and the antiphospholipid syndrome: a link unravelled?
Shoenfeld Y; Harats D; George J
Lupus; 1998; 7 Suppl 2():S140-3. PubMed ID: 9814692
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies and myocardial infarction.
Vaarala O
Lupus; 1998; 7 Suppl 2():S132-4. PubMed ID: 9814690
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
Kobayashi K; Lopez LR; Matsuura E
Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
[TBL] [Abstract][Full Text] [Related]
17. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
19. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
[TBL] [Abstract][Full Text] [Related]
20. Beta2-glycoprotein I: target antigen for 'antiphospholipid' antibodies. Immunological and molecular aspects.
Sheng Y; Kandiah DA; Krilis SA
Lupus; 1998; 7 Suppl 2():S5-9. PubMed ID: 9814663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
